Hovione to Buy Irish Pharma Ingredients Site from Pfizer

Privately owned pharmaceutical ingredients manufacturer Hovione (Loures, Portugal) says it has agreed to buy Pfizer’s multipurpose active pharma ingredients (API) plant at Loughbeg, Ireland. The deal is scheduled to be completed by early April 2009. Financial terms were not disclosed.   The site, to be renamed Hovione Cork, manufactures intermediates for API ingredients used in the cholesterol-lowering drug Lipitor. Hovione says as part of the deal that it will continue to provide manufacturing services for Pfizer. The multipurpose plant adds 427 cubic...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers